Latest Regulatory Approvals News

Bindi Metals Limited has announced a non-renounceable entitlement offer of options to raise approximately $46,000, underwritten by CPS Capital Group. The offer includes 46 million options to shareholders and 5 million options to the lead manager, with potential dilution if exercised.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a brief delay as FIRB extends its approval deadline, prompting a reschedule of the critical court hearing to November 23.

Kore Potash has raised approximately US$12.2 million through a new share issue to fund critical project payments and maintain working capital for the next year. The fundraise also opens the door for major shareholders to increase their stakes, pending approvals.

St Barbara Limited reports solid progress on its Simberi Expansion Project and Atlantic 15-Mile Processing Hub, with key milestones reached and strategic options under review.

Cuscal Limited has received final regulatory approval from APRA for its full acquisition of Indue Limited, setting the stage for completion by early December.

Charter Hall Group reported solid FY25 financial results with significant earnings growth and sustainability milestones, while guiding higher earnings and distributions for FY26.

State Gas Limited has independently certified a maiden 2P gas reserve of 30.2 petajoules at its Rolleston West Project, establishing a solid foundation for a pipeline-connected gas development aimed at the east coast market.

Cyprium Metals has secured board approval to restart copper cathode production at its Nifty Copper Complex, targeting first output by mid-2026. The plan leverages existing heap leach resources and refurbishes key processing infrastructure to generate near-term cash flow.

Amplia Therapeutics has secured positive feedback from the US FDA on its Phase 2b/3 trial design for narmafotinib in pancreatic cancer, paving the way for a late 2026 trial start.

Aureka Limited has reported exceptional high-grade gold assay results from its St Arnaud Comstock Project, including a record 0.3m intercept grading 109g/t gold, extending mineralisation beyond current resource boundaries.

HeraMED has achieved a significant regulatory milestone with the Therapeutic Goods Administration upgrading its HeraBEAT fetal heart rate monitor to Class IIb, making it the only remote home-use device approved in Australia. This positions the company for a potentially lucrative expansion in the Australian maternity care market.

Hansen Technologies reported robust FY25 results driven by double-digit revenue growth, strategic contract wins, and a transformative acquisition of UK-based Digitalk. The company’s integration of AI and sustainability initiatives underpin a confident outlook for sustained growth.